Corrigendum to “Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection” [Vaccine 42 (1–12) (2024) 126325]

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2024-11-05 DOI:10.1016/j.vaccine.2024.126480

Susan D. Kerfua , Daniel T. Haydon , Ginette Wilsden , Anna Ludi , Donald P. King , Rose Ademun Okurut , Stella Atim , Moses T. Dhikusooka , Ivan Kyakuwa , Paolo Motta , David J. Paton

引用次数: 0

查看原文本刊更多论文

针对东非病毒株的商用四价口蹄疫疫苗评估显示免疫原性和保护期有限》[疫苗 42 (1-12) (2024) 126325]更正

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.